Authors:
Julian-Reynier, C
Eisinger, F
Moatti, JP
Sobol, H
Citation: C. Julian-reynier et al., Re: Randomized trial of a specialist genetic assessment service for familial breast cancer, J NAT CANC, 93(2), 2001, pp. 158-159
Authors:
Ricevuto, E
Sobol, H
Stoppa-Lyonnet, D
Gulino, A
Marchetti, P
Ficorella, C
Martinotti, S
Meo, T
Tosi, M
Citation: E. Ricevuto et al., Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons, CLIN CANC R, 7(6), 2001, pp. 1638-1646
Authors:
Eisinger, F
Charafe-Jauffret, E
Jacquemier, J
Birnbaum, D
Julian-Reynier, C
Sobol, H
Citation: F. Eisinger et al., Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact, INT J ONCOL, 18(1), 2001, pp. 5-10
Authors:
Jacquemier, J
Lidereau, R
Birnbaum, D
Eisinger, F
Sobol, H
Citation: J. Jacquemier et al., Assessing the risk of BRCA1-associated breast cancer using individual morphological criteria, HISTOPATHOL, 38(4), 2001, pp. 378-379
Authors:
McKay, JD
Lesueur, F
Jonard, L
Pastore, A
Williamson, J
Hoffman, L
Burgess, J
Duffield, A
Papotti, M
Stark, M
Sobol, H
Maes, B
Murat, A
Kaariainen, H
Bertholon-Gregoire, M
Zini, M
Rossing, MA
Toubert, ME
Bonichon, F
Cavarec, M
Bernard, AM
Boneu, A
Leprat, F
Haas, O
Lasset, C
Schlumberger, M
Canzian, F
Goldgar, DE
Romeo, G
Citation: Jd. Mckay et al., Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21, AM J HU GEN, 69(2), 2001, pp. 440-446
Authors:
Lakhani, SR
Gusterson, BA
Jacquemier, J
Sloane, JP
Anderson, TJ
van de Vijver, MJ
Venter, D
Freeman, A
Antoniou, A
McGuffog, L
Smyth, E
Steel, CM
Haites, N
Scott, RJ
Goldgar, D
Neuhausen, S
Daly, PA
Ormiston, W
McManus, R
Scherneck, S
Ponder, BAJ
Futreal, PA
Peto, J
Stoppa-Lyonnet, D
Bignon, YJ
Struewing, JP
Bishop, DT
Klijn, JGM
Devilee, P
Cornelisse, CJ
Lasset, C
Lenoir, G
Barkardottir, RB
Egilsson, V
Hamann, U
Chang-Claude, J
Sobol, H
Weber, B
Easton, DF
Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Authors:
Julian-Reynier, C
Sobol, H
Sevilla, C
Nogues, C
Bourret, P
Citation: C. Julian-reynier et al., Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families, PSYCHO-ONC, 9(6), 2000, pp. 504-510
Authors:
Adelaide, J
Chaffanet, M
Mozziconacci, MJ
Popovici, C
Conte, N
Fernandez, F
Sobol, H
Jacquemier, J
Pebusque, MJ
Ron, D
Lafage-Pochitaloff, M
Birnbaum, D
Citation: J. Adelaide et al., Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line, INT J ONCOL, 16(4), 2000, pp. 683-688
Authors:
Julian-Reynier, C
Eisinger, F
Moatti, JP
Sobol, H
Citation: C. Julian-reynier et al., Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines, EUR J HUM G, 8(3), 2000, pp. 204-208
Authors:
Julian-Reynier, C
Eisinger, F
Chabal, F
Lasset, C
Nogues, C
Stoppa-Lyonnet, D
Vennin, P
Sobol, H
Citation: C. Julian-reynier et al., Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors, AM J MED G, 94(1), 2000, pp. 13-18
Authors:
Lidereau, R
Eisinger, F
Champeme, MH
Nogues, C
Bieche, I
Birnbaum, D
Pallud, C
Jacquemier, J
Sobol, H
Citation: R. Lidereau et al., Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer, CANCER RES, 60(5), 2000, pp. 1206-1210
Authors:
Eisinger, F
Jacquemier, J
Charafe-Jauffret, E
Rio, MC
Birnbaum, D
Sobol, H
Citation: F. Eisinger et al., More about: Multifactorial analysis of differences between sporadic breastcancers and cancers involving BRCA1 and BRCA2 mutations, J NAT CANC, 91(16), 1999, pp. 1421-1422
Citation: F. Eisinger et H. Sobol, Comments on: Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancerclinics, Vasen et al., Eur J Cancer 1998, 34, 1922-1926, EUR J CANC, 35(5), 1999, pp. 859-860
Authors:
Sobol, H
Bignon, YJ
Bonaiti, C
Cuisenier, J
Lasset, C
Lortholary, A
Nogues, C
Stoppa-Lyonnet, D
Eisinger, F
Citation: H. Sobol et al., Four years analysis of cancer genetic clinics activity in France from 1994to 1997: A survey on 801 patients, DIS MARKER, 15(1-3), 1999, pp. 15-29
Authors:
Eisinger, F
Nogues, C
Guinebretiere, JM
Peyrat, JP
Bardou, VJ
Noguchi, T
Vennin, P
Sauvin, R
Lidereau, R
Birnbaum, D
Jacquemier, J
Sobol, H
Citation: F. Eisinger et al., Novel indications for BRCA1 screening using individual clinical and morphological features, INT J CANC, 84(3), 1999, pp. 263-267